Health Care · Biological Products, (No Diagnostic Substances) · Nasdaq · CIK 2020932 · FYE Dec 31 · Prices AT CLOSE 2026-07-28 (USD) — end-of-day, never a live or intraday quote
Last $12.54Day +0.24%Off 52W high −29.6%Vol (1Y) 99.9%
Daily closing price, split-adjusted to the current basis; 0.4y shown of 108 bars on file. Sampled to 108 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest3.6% of sh out |
| Days to cover14.6d |
| Top-10 13F concentration87.9% |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
No standardized fundamentals available.
No return windows available for AGMB.
| Ann. volatility (1Y)99.9% |
| Ann. volatility (3Y)99.9% |
| Sharpe (1Y)0.13 |
| Sharpe (3Y)0.13 |
| Max drawdown (1Y)−40.7% |
| Max drawdown (3Y)−40.7% |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| EQT Fund Management S.a r.l. | 5.1M | $54M | 15.05% | new |
| Sanofi | 2.8M | $29M | 8.15% | new |
| Cormorant Asset Management, LP | 2.5M | $26M | 7.22% | new |
| TCG Crossover Management, LLC | 2.1M | $22M | 6.01% | new |
| FEDERATED HERMES, INC. | 1.6M | $17M | 4.74% | new |
| Casdin Capital, LLC | 1.6M | $16M | 4.54% | new |
| ANDERA PARTNERS | 1.5M | $16M | 4.50% | new |
| FMR LLC | 1.5M | $15M | 4.27% | new |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
No reported quarters on file for AGMB.
